The persistent elimination of B cells responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: novel concept in preventing antibody-mediated rejection in ABO-incompatible transplantation
Authors:
- 15 December 2007
- journal article
- Published by American Society of Hematology in Blood
- Vol. 110 (13) , 4567-4575
Abstract
We demonstrated a novel strategy for specific and persistent inhibition of antibody (Ab) production against blood group A or B carbohydrate determinants necessary for successful ABO-incompatible transplantation. Similar to human blood group O or B individuals, mice have naturally occurring Abs against human blood group A carbohydrates in their sera. B cells with receptors for A carbohydrates in mice belonging to the CD5+CD11b+B-1a subset have phenotypic properties similar to those of human B cells. These cells could be temporarily eliminated by injecting synthetic A carbohydrates (GalNAcα1–3, Fucα1–2Gal) conjugated to bovine serum albumin (A-BSA) and anti-BSA Abs. In mice that received the injection of A-BSA/anti-BSA Abs, the serum levels of anti-A IgM were reduced, but immunization with human A erythrocytes resulted in increased serum levels of anti-A Abs. When combined with cyclosporin A (CsA) treatment, which blocks B-1a cell differentiation, and treatment with A-BSA/anti-BSA Abs, the serum levels of anti-A Abs were persistently undetectable in the mice even after the immunization. B cells with receptors for A carbohydrates were markedly reduced in these mice. These results are consistent with the hypotheses that treatment with A-BSA/anti-BSA Abs temporarily depletes B cells responding to A determinants, and CsA treatment prevents the replenishment of these cells.Keywords
This publication has 47 references indexed in Scilit:
- NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinantTransplant Immunology, 2003
- Normal Levels of Allo- but Increased Levels of Potentially Autoreactive Antibodies against ABO Histo-Blood Group Antigens in AIDS PatientsClinical Immunology and Immunopathology, 1996
- A REASSESSMENT OF ABO INCOMPATIBILITY IN PEDIATRIC LIVER TRANSPLANTATIONTransplantation, 1995
- SUCCESSFUL USE OF AN ENHANCED IMMUNOSUPPRESSIVE PROTOCOL WITH PLASMAPHERESIS FOR ABO-INCOMPATIBLE MISMATCHED GRAFTS IN LIVER TRANSPLANT RECIPIENTSTransplantation, 1995
- Preformed antibody and complement rebound after plasma exchange: analysis of immunoglobulin isotypes and effect of splenectomyTransplant Immunology, 1994
- Cyclosporin-a sensitive induction of NF-AT in murine B cellsImmunity, 1994
- B-1 cells are made, not bornImmunology Today, 1993
- Are bacterial endotoxins involved in autoimmunity by CD5+ (Ly-1+) B cells?Immunology Today, 1989
- Immunoadsorption for Removal of a and B Blood-Group AntibodiesNew England Journal of Medicine, 1981
- Developmental Patterns of ABO Isoagglutinins in Normal Children Correlated with the Effects of Age, Sex, and Maternal IsoagglutininsTransfusion, 1974